CUSIP 28036F105 · who reports it, how much, and how much it matters to them
33 of the 720 hedge fund managers we track reported shares of Edgewise Therapeutics, Inc. (Nasdaq: EWTX) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Orbimed Advisors, at USD 631m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Orbimed Advisors1 fund on PPLI.com | USD 631m | 11.7% |
| 2 | Ra Capital Management1 fund on PPLI.com | USD 341m | 3.0% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 178m | 2.7% |
| 4 | Baker Bros. Advisors2 funds on PPLI.com | USD 150m | 0.8% |
| 5 | Cormorant Asset Management1 fund on PPLI.com | USD 102m | 5.2% |
| 6 | Braidwell12 funds on PPLI.com | USD 81m | 3.0% |
| 7 | Artisan Partners1 fund on PPLI.com | USD 23m | 0.0% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 19m | 0.0% |
| 9 | Adage Capital Management1 fund on PPLI.com | USD 19m | 0.0% |
| 10 | Sofinnova Investments1 fund on PPLI.com | USD 15m | 0.8% |
| 11 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 10m | 0.0% |
| 12 | Dafna Capital Management6 funds on PPLI.com | USD 9.2m | 1.8% |
| 13 | D. E. Shaw & Co.15 funds on PPLI.com | USD 7.7m | 0.0% |
| 14 | POINT72 Asset Management17 funds on PPLI.com | USD 4.8m | 0.0% |
| 15 | Artia Global Partners1 fund on PPLI.com | USD 4m | 0.7% |
| 16 | HighVista Strategies27 funds on PPLI.com | USD 3.7m | 0.8% |
| 17 | Ally Bridge Group (Ny)3 funds on PPLI.com | USD 3.4m | 3.0% |
| 18 | Boothbay Fund Management2 funds on PPLI.com | USD 3.4m | 0.0% |
| 19 | Persistent Asset Partners10 funds on PPLI.com | USD 2.8m | 0.8% |
| 20 | Tudor Investment Corporation10 funds on PPLI.com | USD 2.3m | 0.0% |
| 21 | Two Sigma Investments35 funds on PPLI.com | USD 2m | 0.0% |
| 22 | Aquatic Capital Management3 funds on PPLI.com | USD 1.5m | 0.1% |
| 23 | Verdad Advisers6 funds on PPLI.com | USD 1.1m | 1.1% |
| 24 | Brevan Howard Capital Management39 funds on PPLI.com | USD 1.1m | 0.0% |
| 25 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 968,000 | 0.1% |
| 26 | LMR Partners2 funds on PPLI.com | USD 813,000 | 0.0% |
| 27 | J. Goldman & Co.1 fund on PPLI.com | USD 414,000 | 0.0% |
| 28 | Verition Fund Management3 funds on PPLI.com | USD 406,000 | 0.0% |
| 29 | Lion Point Capital1 fund on PPLI.com | USD 370,000 | 1.8% |
| 30 | Engineers Gate Manager1 fund on PPLI.com | USD 271,000 | 0.0% |
| 31 | Marshall Wace LLP84 funds on PPLI.com | USD 248,000 | 0.0% |
| 32 | Squarepoint Ops7 funds on PPLI.com | USD 230,000 | 0.0% |
| 33 | The Quarry1 fund on PPLI.com | USD 2,885 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Orbimed Advisors | USD 631m | 11.7% |
| 2 | Cormorant Asset Management | USD 102m | 5.2% |
| 3 | Braidwell | USD 81m | 3.0% |
| 4 | Ally Bridge Group (Ny) | USD 3.4m | 3.0% |
| 5 | Ra Capital Management | USD 341m | 3.0% |
| 6 | Perceptive Advisors | USD 178m | 2.7% |
| 7 | Lion Point Capital | USD 370,000 | 1.8% |
| 8 | Dafna Capital Management | USD 9.2m | 1.8% |
| 9 | Verdad Advisers | USD 1.1m | 1.1% |
| 10 | HighVista Strategies | USD 3.7m | 0.8% |
Edgewise Therapeutics, Inc. trades under the symbol EWTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 28036F105.
33 of the 720 hedge fund managers PPLI.com tracks reported Edgewise Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Orbimed Advisors (USD 631m), Ra Capital Management (USD 341m), Perceptive Advisors (USD 178m), Baker Bros. Advisors (USD 150m) and Cormorant Asset Management (USD 102m).
33 managers in our coverage reported it, and between them they run 370 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Orbimed Advisors, where the position was 11.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Edgewise Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.